Massachusetts Financial Services’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-38,970
| Closed | -$4.15M | – | 840 |
|
|
2023
Q2 | $4.15M | Buy |
38,970
+16,215
| +71% | +$1.73M | ﹤0.01% | 654 |
|
|
2023
Q1 | $6.79M | Sell |
22,755
-5,705
| -20% | -$1.7M | ﹤0.01% | 628 |
|
|
2022
Q4 | $9.78M | Buy |
28,460
+93
| +0.3% | +$32K | ﹤0.01% | 611 |
|
|
2022
Q3 | $5.37M | Buy |
28,367
+1,928
| +7% | +$365K | ﹤0.01% | 647 |
|
|
2022
Q2 | $5.58M | Sell |
26,439
-197
| -0.7% | -$41.6K | ﹤0.01% | 647 |
|
|
2022
Q1 | $8.91M | Buy |
26,636
+731
| +3% | +$245K | ﹤0.01% | 645 |
|
|
2021
Q4 | $8.43M | Sell |
25,905
-189
| -0.7% | -$61.5K | ﹤0.01% | 671 |
|
|
2021
Q3 | $12.7M | Buy |
26,094
+8,109
| +45% | +$3.94M | ﹤0.01% | 654 |
|
|
2021
Q2 | $8.36M | Sell |
17,985
-53
| -0.3% | -$24.6K | ﹤0.01% | 680 |
|
|
2021
Q1 | $12.5M | Sell |
18,038
-435
| -2% | -$300K | ﹤0.01% | 647 |
|
|
2020
Q4 | $13.7M | Buy |
18,473
+341
| +2% | +$252K | ﹤0.01% | 621 |
|
|
2020
Q3 | $12.6M | Sell |
18,132
-446
| -2% | -$309K | ﹤0.01% | 610 |
|
|
2020
Q2 | $15.8M | Buy |
18,578
+1,428
| +8% | +$1.21M | 0.01% | 572 |
|
|
2020
Q1 | $6.13M | Buy |
+17,150
| New | +$6.13M | ﹤0.01% | 626 |
|